Eton Pharmaceuticals, Inc. (ETON) P/S ratio

P/S ratio today
21.4×

Eton Pharmaceuticals, Inc. (ETON) trades at 21.4× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 5.7×. That is 35.6% lower than the 8.8× of fiscal 2024. Figures as of 18 Nov 2026, 08:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
21.4×
P/S ratio, fiscal 2025
5.7×
Change on fiscal 2024
−35.6%
Highest on record
8.8×fiscal 2024
Lowest on record
3.3×fiscal 2022
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Eton Pharmaceuticals, Inc. P/S ratio, in more detail

Today's figure is 276.4% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 8.8× in fiscal 2024 and the lowest 3.3× in fiscal 2022. Today's P/S ratio is above every one of the 5 fiscal year-ends on record; their median is 5.0×.

History · 5 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Eton Pharmaceuticals, Inc. P/S ratio, year by year

Eton Pharmaceuticals, Inc. (ETON) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today21.4×—$63.65—
20255.7× 35.6% down$16.91$2.97
20248.8× 149.1% up$13.32$1.51
20233.5× 6.4% up$4.38$1.23
20223.3× 32.6% down$2.82$0.85
20215.0×—$4.29$0.87
2020——$8.13$0.00
2019——$7.20—
2018——$6.12—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on ETON

Eton Pharmaceuticals, Inc., figure by figure

Eton Pharmaceuticals, Inc. (ETON) overview: price, valuation and scorecard

Eton Pharmaceuticals, Inc. P/S ratio: questions and answers

What is Eton Pharmaceuticals, Inc.'s P/S ratio?

Eton Pharmaceuticals, Inc. (ETON) trades at 21.4× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 5.7×. That is 35.6% lower than the 8.8× of fiscal 2024.

Is Eton Pharmaceuticals, Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is above every one of the 5 fiscal year-ends on record; their median is 5.0×.

What are the highest and lowest P/S ratio figures on record for Eton Pharmaceuticals, Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 8.8× in fiscal 2024 and the lowest 3.3× in fiscal 2022.

How is Eton Pharmaceuticals, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Eton Pharmaceuticals, Inc. (ETON) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ETON/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.